Affiliation
Christie NHS Foundation Trust, Manchester M20 4BXIssue Date
2016-07
Metadata
Show full item recordCitation
Sequential immunotherapy regimens - expect the unexpected. 2016, 17 (7):854-5 Lancet Oncol.Journal
The Lancet. OncologyDOI
10.1016/S1470-2045(16)30198-XPubMed ID
27269742Type
ArticleLanguage
enISSN
1474-5488ae974a485f413a2113503eed53cd6c53
10.1016/S1470-2045(16)30198-X
Scopus Count
Collections
Related articles
- Immuno-pharmacodynamics for evaluating mechanism of action and developing immunotherapy combinations.
- Authors: Parchment RE, Voth AR, Doroshow JH, Berzofsky JA
- Issue date: 2016 Aug
- The New Era of Cancer Immunotherapy: Manipulating T-Cell Activity to Overcome Malignancy.
- Authors: Khalil DN, Budhu S, Gasmi B, Zappasodi R, Hirschhorn-Cymerman D, Plitt T, De Henau O, Zamarin D, Holmgaard RB, Murphy JT, Wolchok JD, Merghoub T
- Issue date: 2015
- Renal carcinoma (RC): regulation of antitumoral immune responses.
- Authors: Heicappell R, Ackermann R
- Issue date: 1992
- Recombinant interleukin-2-based treatments for advanced melanoma: the experience of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group.
- Authors: Keilholz U, Stoter G, Punt CJ, Scheibenbogen C, Lejeune F, Eggermont AM
- Issue date: 1997 Dec
- Efficacy of combined intravesical immunotherapy and chemotherapy for non-muscle invasive bladder cancer.
- Authors: Hilton WM, Ercole B, Parekh DJ, Sonpavde G, Ghosh R, Svatek RS
- Issue date: 2011 Jun